{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:01:16Z","timestamp":1762326076086,"version":"3.40.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpba.2025.116713","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:56:31Z","timestamp":1738083391000},"page":"116713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structure elucidation and confirmation of unknown impurities in an animal health product by the strategy of utilizing a variety of advanced analytical techniques"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-4873","authenticated-orcid":false,"given":"Jiangtao","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Dissanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-8915","authenticated-orcid":false,"given":"Jingzhi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu","family":"Rustum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116713_bib1","unstructured":"FDA, Guidance for Industry Q3B(R2) Impurities in New Drug Products, (n.d.). \u3008https:\/\/www.fda.gov\/media\/71733\/download\u3009 (accessed October 30, 2024)."},{"key":"10.1016\/j.jpba.2025.116713_bib2","unstructured":"EMA, The European Medicines Agency\u2019s scientific guidelines on impurities in drug products and drug substances, (n.d.). \u3008https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-and-development\/scientific-guidelines\/quality-guidelines\/quality-impurities\u3009 (accessed October 30, 2024)."},{"key":"10.1016\/j.jpba.2025.116713_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/10408347.2016.1169913","article-title":"Development of Impurity Profiling Methods Using Modern Analytical Techniques","volume":"47","author":"Ramachandra","year":"2017","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116713_bib4","unstructured":"FDA, Container Closure Systems for Packaging Human Drugs and Biologics, (n.d.). \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/container-closure-systems-packaging-human-drugs-and-biologics\u3009 (accessed October 30, 2024)."},{"key":"10.1016\/j.jpba.2025.116713_bib5","unstructured":"EMA, Guideline on Primary Plastic Packaging Materials, (n.d.). \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-plastic-immediate-packaging-materials_en.pdf\u3009 (accessed October 30, 2024)."},{"key":"10.1016\/j.jpba.2025.116713_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11095-007-9521-z","article-title":"Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations","volume":"25","author":"Norwood","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2025.116713_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acsbiomaterials.1c01119","article-title":"Chemical characterization and non-targeted analysis of medical device extracts: a review of current approaches, gaps, and emerging practices","volume":"8","author":"Sussman","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jpba.2025.116713_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116286","article-title":"Analytical challenges and recent advances in the identification and quantitation of extractables and leachables in pharmaceutical and medical products","volume":"141","author":"Singh","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116713_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s41783-023-00157-8","article-title":"Systematic approaches on extractable and leachable study designs in pharmaceuticals and medical devices: a review","volume":"7","author":"Sharma","year":"2023","journal-title":"J. Packag. Technol. Res."},{"key":"10.1016\/j.jpba.2025.116713_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jpba.2007.08.021","article-title":"Identification of an unknown extraneous contaminant in pharmaceutical product analysis","volume":"45","author":"Lin","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116713_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/molecules24030611","article-title":"An organic chemist\u2019s guide to electrospray mass spectrometric structure elucidation","volume":"24","author":"Steckel","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2025.116713_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trac.2014.03.013","article-title":"Derivatization for liquid chromatography-mass spectrometry","volume":"59","author":"Qi","year":"2014","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116713_bib13","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/rcm.6968","article-title":"Loss of H2 and CO from protonated aldehydes in electrospray ionization mass spectrometry","volume":"28","author":"Neta","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116713_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120172","article-title":"Use of ammonium sulfite as a post-column derivatization reagent for rapid detection and quantification of aldehydes by LC-MS","volume":"206","author":"Hu","year":"2020","journal-title":"Talanta"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T16:46:04Z","timestamp":1744821964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":14,"alternative-id":["S0731708525000548"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116713","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure elucidation and confirmation of unknown impurities in an animal health product by the strategy of utilizing a variety of advanced analytical techniques","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116713"}}